Market Research Logo

Global Systemic Lupus Erythematosus (SLE) Drugs Market 2015-2019

About SLE

SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and destroy healthy tissues in the body rather than foreign infectious agents. These autoantibodies cause inflammation, pain, and damage. It is also known as a disease of flare-ups and remissions and can range from mild to life threatening in severity. No cure for SLE yet exists.

TechNavio's analysts forecast the Global SLE Drugs market to grow at a CAGR of 22.41 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global SLE Drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of SLE that are available in the market.

TechNavio's report, the Global SLE Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it covers the Global SLE Drugs market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA
Key Vendors
  • Anthera Pharmaceuticals
  • BMS
  • GSK
  • ImmuPharma
  • Merck Serono
  • UCB
Other Prominent Vendors
  • Amgen
  • HGS
  • Immunomedics
  • Johnson & Johnson
  • MedImmune
  • Sanofi
  • Teva Pharmaceutical Industries
Market Driver
  • High Prevalence of Autoimmune Disease
  • For a full, detailed list, view our report
Market Challenge
  • Complex Etiology
  • For a full, detailed list, view our report
Market Trend
  • Increase in Awareness
  • For a full, detailed list, view our report
Key Questions Answered in this Report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Systemic Lupus Erythematosus (SLE) Drugs Market 2015-2019

Technavio recognizes the following companies as the key players in Global Systemic Lupus Erythematosus (SLE) Drugs Market 2015-2019: Anthera Pharmaceuticals Inc, BMS Co, GSK plc, ImmuPharma plc, Merck Serono SA and UCB SA.

Other Prominent Vendors in the market are: Amgen, HGS, Immunomedics, Johnson & Johnson, MedImmune, Sanofi and Teva Pharmaceutical Industries

Commenting on the report, an analyst from Technavio’s team said: “Knowledge about the diagnosis of SLE and its treatment is growing in Europe and Asia, areas where the disease is more prevalent. In addition, numerous public awareness campaigns aimed at increasing awareness levels are also being conducted. For instance, LFA has been implementing various projects to increase federal support for lupus research and services to assist people and families affected by lupus. Similarly, SLE Lupus Foundation's program provides support services to patients and their families to cope with lupus.”

According to the report, the high prevalence of autoimmune disease is a major contributor to the growth of the market. The number of people being diagnosed with SLE has been on the rise. Therefore, the demand for drugs is also increasing.

Further, the report states that the complex etiology of the disease is a major challenge in the market.

Companies Mentioned

Anthera Pharmaceuticals Inc, BMS Co, GSK plc, ImmuPharma plc, Merck Serono SA, UCB SA, Amgen, HGS, Immunomedics, Johnson & Johnson, MedImmune, Sanofi, Teva Pharmaceutical Industries

  • Executive Summary
  • List of Abbreviations
  • Scope of the Report
    • Market overview
    • Product offerings
  • Market Research Methodology
    • Market research process
    • Research methodology
      • Table Market research methodology
  • Introduction
  • Disease Overview
    • Etiology
    • Epidemiology
      • Table Diagnosed prevalent cases of SLE 2014 and 2019
    • Risk factors
    • Quality of life
    • Symptoms
    • Diagnosis
    • Management and treatment
      • Table Overview of management of SLE
  • SLE Pipeline Landscape
  • Market Landscape
    • Market overview
    • Market size and forecast
      • Table Global SLE drugs market 2014-2019 ($ million)
    • SLE drugs market in Americas
      • Market size and forecast
        • Table SLE drugs market in Americas 2014-2019 ($ million)
    • SLE drugs market in Europe
      • Market size and forecast
        • Table SLE drugs market in Europe 2014-2019 ($ million)
  • Market Assessment of Benlysta
    • Table Benlysta: Global revenue 2011-2013 ($ million)
    • Benlysta revenue forecast in US
      • Table Benlysta: Revenue forecast in US 2014-2019 ($ million)
      • Benlysta revenue forecast in 5EU
        • Table Benlysta: Revenue forecast in 5EU 2014-2019 ($ million)
    • Five forces analysis
  • Market Segmentation by Type
    • Table Segmentation of global SLE drugs market by type
  • Market Segmentation by Therapeutic Class
    • Table Segmentation of global SLE drugs market by therapeutic class
  • Geographical Segmentation
    • Table Segmentation of global SLE drugs market by geography 2014
  • Buying Criteria
  • Market Growth Drivers
  • Drivers and their Impact
  • Market Challenges
  • Impact of Drivers and Challenges
  • Market Trends
  • Trends and their Impact
  • Vendor Landscape
    • Competitive scenario
      • Key news
      • Mergers and acquisitions
    • Market share analysis 2014
      • Anthera Pharmaceuticals
      • BMS
        • Table Orencia: Global revenue 2011-2013 ($ million)
      • GSK
      • ImmuPharma
      • Merck Serono
      • UCB
    • Other prominent vendors
  • Key Vendor Analysis
    • Anthera Pharmaceuticals
      • Key facts
      • Business overview
      • Business strategy
      • Recent developments
      • SWOT analysis
    • Bristol-Myers Squibb
      • Key facts
      • Business overview
      • Key product offerings
        • Table Bristol-Myers Squibb Co.: Key Product Offerings (Based on Therapeutic Areas)
      • Revenue by geography
        • Table Bristol-Myers Squibb: Revenue by geographical segmentation 2013
      • Business strategy
      • Key information
      • SWOT analysis
    • GlaxoSmithKline
      • Key facts
      • Business overview
      • Business segmentation
        • Table GlaxoSmithKline: Business segmentation 2013
      • Business segmentation by revenue 2012 and 2013
        • Table GlaxoSmithKline: Business segmentation by revenue 2012 and 2013 (US$ billion)
      • Sales by geography
        • Table GlaxoSmithKline: Sales by geography 2013
      • Pipeline products
        • Table GlaxoSmithKline: Pipeline products 2013
      • Business strategy
      • Key information
      • SWOT analysis
    • ImmuPharma
      • Key facts
      • Business overview
      • Business strategy
      • Recent developments
      • SWOT analysis
    • Merck Serono
      • Key facts
      • Business overview
      • Geographical segmentation by revenue 2013
        • Table Merck Serono: Geographical segmentation by revenue 2013
      • Business strategy
      • Recent developments
      • SWOT analysis
    • UCB
      • Key facts
      • Business overview
      • Product segmentation by revenue 2013
        • Table UCB: Product segmentation by revenue 2013
      • Product segmentation by revenue 2012 and 2013
        • Table UCB: Product segmentation by revenue 2012 and 2013 (US$ million)
      • Geographical segmentation by revenue 2013
        • Table UCB: Geographical segmentation by revenue 2013
      • Business strategy
      • Recent developments
      • SWOT analysis
  • Other Reports in this Series

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report